Viral respiratory tract infections commonly cause hospitalizations, economic losses, morbidity and mortality in the US and worldwide. Influenza A virus (lAV), paramyxoviruses, rhinoviruses, human coronaviruses (HCoV), and other emerging, highly pathogenic respiratory viruses are a major global public health threat. Importantly, viral lung disease severity can range from mild self-limited infections to pneumonia followed by acute respiratory distress syndrome (ARDS) and death. This spectrum complicates treatment algorithms and underlies a critical need for rapid-response etiologic and prognostic indicators that readily inform treatment options in an outbreak setting. The overall goal of this program is to develop new platform technologies to rapidly recover and characterize new and emerging viruses in vitro and in vivo. Secondary objectives are to use functional genomics as diagnostic and prognostic indicators of virulence and disease severity following virus infection of the lung. Using a highly interactive team, we will test the hypothesis that """"""""-omics"""""""" and other physiologic signatures will: i) predict etiology;ii) provide early prognostic indicators of virulence, and iii) inform public health measures and therapeutic responses. The program uses highly pathogenic HCoV strains (severe acute respiratory syndrome coronavirus and HCoV EMC/2012) and lAV strains (H1N1 Ca/04/2009 and H1N1 1918) and various clinical isolates as models.
In Aim 1, we will develop platforms to recover novel respiratory viruses and identify diagnostic and prognostic indicators of severe lung disease by infecting primary human lung cells.
In aim 2, we use the Collaborative Cross Mice to develop new animal models of human disease and to define conserved genomic signatures that correlate with etiology and disease severity and then validate the role of these biomarkers in models of outbred human populations infected with different high and low path respiratory viruses.
In Aim 3, the goal is to use functional genomics and computational biology to not only diagnose virus etiology and forecast disease severity in the lung, but in parallel, develop a highly portable screening platform that rapidly identifies and then validates the lead compounds that attenuate disease severity in robust models of outbred human populations.

Public Health Relevance

The overall goal of this program is to develop new platform technologies that use functional genomics as diagnostic and prognostic indicators of severe end stage lung disease following virus infection of the lung. Using a highly interactive team, we will test the hypothesis that -omics and other physiologic signatures will: predict etiology;ii) provide early prognostic indicators, and iii) inform public health measures and therapeutic responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI109761-01
Application #
8655267
Study Section
Special Emphasis Panel (ZAI1-LR-M (J1))
Project Start
Project End
Budget Start
2014-03-07
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$1,184,414
Indirect Cost
$227,381
Name
Columbia University
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Lindow, Janet C; Wunder Jr, Elsio A; Popper, Stephen J et al. (2016) Cathelicidin Insufficiency in Patients with Fatal Leptospirosis. PLoS Pathog 12:e1005943
Bouilly, Delphine; Hon, Jason; Daly, Nathan S et al. (2016) Single-Molecule Reaction Chemistry in Patterned Nanowells. Nano Lett 16:4679-85
Bacharach, Eran; Mishra, Nischay; Briese, Thomas et al. (2016) Characterization of a Novel Orthomyxo-like Virus Causing Mass Die-Offs of Tilapia. MBio 7:e00431-16
Beall, Anne; Yount, Boyd; Lin, Chun-Ming et al. (2016) Characterization of a Pathogenic Full-Length cDNA Clone and Transmission Model for Porcine Epidemic Diarrhea Virus Strain PC22A. MBio 7:e01451-15
Forero, Adriana; Tisoncik-Go, Jennifer; Watanabe, Tokiko et al. (2016) The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice. J Virol 90:2240-53
Tisoncik-Go, Jennifer; Gasper, David J; Kyle, Jennifer E et al. (2016) Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. Cell Host Microbe 19:254-66
Warren, Steven B; Vernick, Sefi; Romano, Ethan et al. (2016) Complementary Metal-Oxide-Semiconductor Integrated Carbon Nanotube Arrays: Toward Wide-Bandwidth Single-Molecule Sensing Systems. Nano Lett 16:2674-9
Strouts, Fiona R; Popper, Stephen J; Partidos, Charalambos D et al. (2016) Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates. PLoS Negl Trop Dis 10:e0004731
Menachery, Vineet D; Yount Jr, Boyd L; Sims, Amy C et al. (2016) SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A 113:3048-53
Tokarz, Rafal; Sameroff, Stephen; Hesse, Richard A et al. (2015) Discovery of a novel nidovirus in cattle with respiratory disease. J Gen Virol 96:2188-93

Showing the most recent 10 out of 32 publications